Skip to content
TrialScanner

NCT04516915

IMU-838 and Oseltamivir in the Treatment of COVID-19

Phase 2CompletedIMUXCollaborator

Registry record

Lead sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Conditions
Covid 19
Primary completion
May 20, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04516915 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04516915: IMU-838 and Oseltamivir in... | TrialScanner